Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Wariness Brewing within MHLW for Medical Fee to Incentivize Hospital Formularies
July 21, 2021
-
REGULATORY Japan to Receive 50 Million More Doses of Moderna Vaccine
July 21, 2021
-
REGULATORY Key MOF Official Wants Budget Neutrality, Cap to Optimize Drug Costs
July 20, 2021
-
REGULATORY Japan Approves COVID-19 Antibody Cocktail, 1st Drug for Mild Cases
July 20, 2021
-
BUSINESS Arcalis Sees Opportunities in mRNA Drugs, Eyes Tens of Billions of Yen in CDMO Sales
July 19, 2021
-
REGULATORY New Pharma Industry Vision to Set Out Roles of Wholesalers: MHLW Director
July 16, 2021
-
REGULATORY Japan to Lower Moderna Vaccine’s Minimum Age to 12
July 16, 2021
-
BUSINESS Guilty Ruling for Ono Employees Now Final and Binding: Onoact Case
July 15, 2021
-
BUSINESS Eisai Taps Continuous Manufacturing for Tazverik, Eyes Its Use for Other Oncology Assets Too
July 14, 2021
-
REGULATORY Chugai’s Antibody Cocktail Up for PAFSC Review on July 19, 4th COVID-19 Drug If Approved
July 13, 2021
-
COMMENTARY Attention Grows for INES Drug Pricing Proposal; Will It Become Next Card on Reform?
July 12, 2021
-
ACADEMIA Japan Needs Discussions on Target Population of Aducanumab: Clinician
July 12, 2021
-
BUSINESS Fueled by Roivant Deal, Sumitomo Dainippon Accelerating DX as It Looks Beyond Latuda LOE
July 9, 2021
-
BUSINESS FDA Updates Aduhelm Label to Only Cover MCI, Mild Alzheimer’s
July 9, 2021
-
BUSINESS Edirol, Generic Drugs All Now Face Supply Curbs as Nichi-Iko Woes Spill Over
July 8, 2021
-
BUSINESS Bristol Myers Kicks Off COVID-19 Inoculation Program, Eliminates Cost Burden on Employees
July 8, 2021
-
BUSINESS 26 Japan Drug Makers’ Annual Pay Averages 8.21 Million Yen, 5 Firms Top 10 Million Yen Mark
July 7, 2021
-
BUSINESS Astellas Revamping Sales Organization as Product Mix Shifts towards Specialty Area: CEO
July 6, 2021
-
BUSINESS Sagent Jettisons Camostat Mesilate for COVID-19 after PII Miss: Nichi-Iko
July 6, 2021
-
BUSINESS All Ranitidine Tablet Drugs to Be Discontinued in Japan over Carcinogen Woes
July 5, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…